13F

Stock

Madrigal Pharmaceuticals, Inc.

MDGL · held by 16 managers

Reported value

$266.8M

Holders

16

+3 new · −0 exited

Holders’ est. mark

$8M

Price effect on 3 books still in the name

Largest holder

$114.5M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY249.6K$114.5MHeld
BANK OF AMERICA CORP /DE/244.3K$112MHeld
BARCLAYS PLC49.9K$22.9M$7.79MAdded$3.92M
GROUPAMA ASSET MANAGMENT27.4K$12.6MHeld
Allworth Financial LP3.55K$1.63MHeld
FARALLON CAPITAL MANAGEMENT LLC3.32K$1.52MNew
Sanctuary Advisors, LLC1.47K$671.9K$198.6KAdded$286.7K
TUDOR INVESTMENT CORP ET AL926$424.7KHeld
Swiss Life Asset Management Ltd646$296.3KNew
IFP Advisors, Inc371$170.2KHeld
Aventura Private Wealth, LLC62$28.4K$9.67KAdded$9.67K
Leonteq Securities AG56$25.7KNew
MV CAPITAL MANAGEMENT, INC.22$10.1KHeld
Cape Investment Advisory, Inc.9$4.13KHeld
KBC Group NV414$190Held
FNY Investment Advisers, LLC7$3Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.